Bacteria found in the bladders of healthy women differ from bacteria in women with a common form of incontinence, according to researchers from Loyola University Chicago Stritch School of Medicine. These findings, published July 9, 2014, in the American Society for Microbiology's online journal mBio, suggest that bacterial communities may play a role in female urinary health.
"Urgency urinary incontinence (UUI) is a common, yet poorly understood, condition with symptoms similar to urinary tract infections," says Alan Wolfe, PhD, co-investigator and professor of Microbiology and Immunology. "If we can determine that certain bacteria cause UUI symptoms, we may be able to better identify those at risk for this condition and more effectively treat them."
Approximately 15 percent of women suffer from UUI and yet an estimated 40 percent to 50 percent do not respond to conventional treatments. One possible explanation for the lack of response to medication may be the bacteria present in these women.
This study evaluated urine specimens of 90 women with and without UUI symptoms. Samples were collected through a catheter and analyzed using an expanded quantitative urine culture (EQUC) technique. This technique was able to find bacteria that are not identified by the standard culture techniques typically used to diagnose urinary tract syndromes. This study also used 16S rDNA sequencing to classify bacterial DNA. The UUI and non-UUI urinary bacteria differed by group based on both culture type and sequence.
"These findings may have strong implications for the prevention, diagnosis and treatment of women with this form of incontinence," says Paul Schreckenberger, PhD, co-investigator and director of the clinical microbiology laboratory at Loyola University Health System.
Source: Loyola University Health System
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.